Connexin43 drives mitochondrial biogenesis and organelle stress in BRAF-mutant melanoma cells

Metabolic flexibility helps cancer cells survive targeted therapy, and BRAF-mutant melanoma rewires mitochondrial metabolism in response to BRAF/MEK inhibitors (BRAF/MEKi). We previously showed that connexin43 (Cx43) acts as a tumour suppressor in BRAF-mutant melanoma and enhances the response to BRAF/MEKi. Here, we investigated whether mitochondrial remodelling contributes to these effects. Cx43 upregulation promoted mitochondrial biogenesis including selective increase of CI and CV, enhanced oxidative phosphorylation (OXPHOS), and increased reactive oxygen species (ROS) production, alongside DRP1-associated mitochondrial fragmentation. Despite enhanced mitochondrial biogenesis and OXPHOS, Cx43 upregulation was associated with respiratory chain remodelling, characterised by loss of complex IV, increased ER and mitochondrial stress, and enhanced mTORC1-associated signalling. These changes were accompanied by an adaptive unfolded protein response that did not engage the pro-apoptotic ATF4-CHOP axis. Notably, BRAF/MEK inhibition largely attenuated the mitochondrial biogenesis phenotype and most of the stress markers associated with Cx43 upregulation, while promoting mitochondrial network elongation and markedly increasing mitochondrial ROS. Despite this impact, Cx43-expressing tumour cells retained higher membrane potential, ROS levels and survival under glucose-limiting conditions. Collectively, these findings reveal a dissociation between the mitochondrial effects of Cx43 and its enhancement of the response to BRAF/MEKi, highlighting the complexity of Cx43-mediated metabolic regulation in BRAF-mutant melanoma. By distinguishing mitochondrial remodelling from therapeutic sensitisation, this study provides new insights into the response to BRAF/MEK inhibition and highlights mTORC1-associated signalling and mitochondrial oxidative stress as potential therapeutic vulnerabilities for further investigation.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-19
DOI
https://doi.org/10.64898/2026.11.18.767001
Primary Topic
Melanoma and MAPK Pathways
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Connexin43 drives mitochondrial biogenesis and organelle stress in BRAF-mutant melanoma cells

Carlos Fernández-Lozano, Teresa Calleja-Chuclá, Paula Carpintero-Fernández, María D. Mayán et al.
bioRxiv (Cold Spring Harbor Laboratory)
Melanoma and MAPK Pathways
preprint

Connexin43 drives mitochondrial biogenesis and organelle stress in BRAF-mutant melanoma cells

Carlos Fernández-Lozano, Teresa Calleja-Chuclá, Paula Carpintero-Fernández, María D. Mayán, Amanda Guitián‐Caamaño, Eva Fernández-Bejarano, Diego González-Pérez, Cristina De Jesús-Sen, Eduardo Fonseca
preprint en

Abstract

Metabolic flexibility helps cancer cells survive targeted therapy, and BRAF-mutant melanoma rewires mitochondrial metabolism in response to BRAF/MEK inhibitors (BRAF/MEKi). We previously showed that connexin43 (Cx43) acts as a tumour suppressor in BRAF-mutant melanoma and enhances the response to BRAF/MEKi. Here, we investigated whether mitochondrial remodelling contributes to these effects. Cx43 upregulation promoted mitochondrial biogenesis including selective increase of CI and CV, enhanced oxidative phosphorylation (OXPHOS), and increased reactive oxygen species (ROS) production, alongside DRP1-associated mitochondrial fragmentation. Despite enhanced mitochondrial biogenesis and OXPHOS, Cx43 upregulation was associated with respiratory chain remodelling, characterised by loss of complex IV, increased ER and mitochondrial stress, and enhanced mTORC1-associated signalling. These changes were accompanied by an adaptive unfolded protein response that did not engage the pro-apoptotic ATF4-CHOP axis. Notably, BRAF/MEK inhibition largely attenuated the mitochondrial biogenesis phenotype and most of the stress markers associated with Cx43 upregulation, while promoting mitochondrial network elongation and markedly increasing mitochondrial ROS. Despite this impact, Cx43-expressing tumour cells retained higher membrane potential, ROS levels and survival under glucose-limiting conditions. Collectively, these findings reveal a dissociation between the mitochondrial effects of Cx43 and its enhancement of the response to BRAF/MEKi, highlighting the complexity of Cx43-mediated metabolic regulation in BRAF-mutant melanoma. By distinguishing mitochondrial remodelling from therapeutic sensitisation, this study provides new insights into the response to BRAF/MEK inhibition and highlights mTORC1-associated signalling and mitochondrial oxidative stress as potential therapeutic vulnerabilities for further investigation.

bioRxiv (Cold Spring Harbor Laboratory)
Universidade da Coruña (ES), Universidade de Santiago de Compostela (ES), Center for Research in Molecular Medicine and Chronic Diseases (ES), Complexo Hospitalario Universitario A Coruña (ES), Servicio Gallego de Salud (ES), Instituto de Investigación Biomédica de A Coruña (ES), Universidade de Vigo (ES)
Melanoma and MAPK Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon